Condition: Prostate Cancer · Sponsor: Anhui Provincial Hospital
The goal of this study is to evaluate the diagnostic value of different ADC values (incuding ADCmin, ADCmean, ADCratio and ADCrange) of bpMRI in patients with PI-RADS 3-5. The main aim is to evaluate whether different ADC values improve the diagnosis of clinically significant prostate cancer (Gleasonscore≥3+4, ISUP grade ≥2) and any-grade prostate cancer (Gleasonscore≥3+3, ISUP grade ≥1).
This description comes directly from the study's public registry record.
Changming Wang · 15840256553 · wcmurologist@mail.ustc.edu.cn
Jun Xiao · 13956934087 · anhuiurology@126.com
Always discuss trial participation with your own doctor first.
| Department of Urology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China | Hefei, Anhui, China | Recruiting |
| Department of Urology, The First Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06737588